SYNTHESIS AND CHARACTERIZATION OF CEFADROXIL-BENZALDEHYDE DERIVED LIGAND, METAL COMPLEXES, AND EVALUATION OF THEIR ANTI-INFLAMMATORY, CYTOTOXIC, AND ANTIMICROBIAL ACTIVITIES
Keywords:
antibacterial, cefadroxil, NMR spectra, schiff base ligand, UVAbstract
Background: The rise of infectious diseases and drug-resistant strains of bacteria and fungi poses a significant challenge, threatening human health and life expectancy. Researchers are actively working to develop novel antimicrobial therapies to counteract these issues.
Methods: In this study, new derivatives were synthesized from (6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo [4.2.0]oct-2-ene-2-carboxylic acid (cefadroxil) by reaction with Benzaldehyde. The primary aim was to enhance the antibacterial efficacy of existing antibiotics and develop therapeutically active compounds. The synthesized ligand was characterized through elemental analysis, various physicochemical tests, and multiple spectroscopic techniques, including infrared (IR), 1H NMR, 13C NMR, and UV spectroscopy. The ligand underwent solubility and chemical tests and was screened for in vitro antibacterial activity using the disc diffusion method. Anti-inflammatory and antioxidant properties were also evaluated.
Results: Synthesized compound exhibited superior antibacterial properties compared to cefadroxil alone, with significant zones of inhibition and MIC values. Additionally, anti-inflammatory and cytotoxicity tests yielded promising outcomes, indicating potential for future antibiotic applications.
Conclusion: Study concludes that while metal coordination with structural modifications could lead to the discovery of novel lead compounds with enhanced therapeutic potential.
Peer Review History:
Received 27 July 2026; Reviewed 5 September 2026; Accepted 3 October; Available online 15 November 2026
Academic Editor: Dr. Amany Mohamed Alboghdadly
, Ibn Sina National College for Medical Studies in Jeddah, Saudi Arabia, [email protected]
Reviewers:
Dr. Kian Navaee, Shahre Daru Pharmaceutical Co., Iran, [email protected]
Dr. Noha El Baghdady, MTI University, Cairo, Egypt, [email protected]
Downloads
Published
How to Cite
Issue
Section
Copyright (c) 2026 Universal Journal of Pharmaceutical Research

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.




.